GSH-Responsive Prodrug Nanoassembly as a Carrier-Free Nanoplatform for Tumor-Targeting Delivery and Chemo-Photothermal Therapy
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.3c00319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Baocheng Tian und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Binzhou Medical University, Yantai 264003, China. Hauptthemen laut MEDLINE: Prodrugs, Nanoparticles, Hyperthermia, Induced. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Photothermal therapy, combined with chemotherapy, holds promising prospects for the therapeutic outcome of malignant tumors. However, the synergistic therapeutic effect suffers from low coloading capacity and inefficient synchronous tumor-targeting delivery of chemodrug and photothermal photosensitizers. Herein, we designed a versatile carrier-free nanoplatform to seek improvement for chemo-photothermal therapy. An NIR photosensitizer IR-808 was used for noninvasive cancer imaging, diagnosis, and imaging-guided photothermal therapy. A reduction-sensitive paclitaxel prodrug (PTX-SS-PEG2k) was rationally synthesized by covalently linking paclitaxel with polyethylene glycol 2000 via a disulfide bond. Then, the carrier-free nanoassemblies were constructed with an inner core of IR-808 and an amphiphilic paclitaxel prodrug shell. PTX-SS-PEG2k served as a stabilizer and chemodrug and could facilitate the self-assembly of IR-808 nanoparticles with high coloading efficiency and reduction-sensitive drug release. The versatile nanoplatform exhibited multiple advantages, including high drug payload, reduction-sensitive drug release, tumor-targeting drug delivery, and potent synergistic antitumor effect. We provide a versatile theranostic nanoplatform, which improves the effectiveness of synergetic chemo-photothermal therapy and reduces the off-target toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Binzhou Medical University, Yantai 264003, China.
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
ORCID-Profile: Qingzhi Lv
Zitieren
APA
Tian, B., Xu, H., Wang, H., Li, K., Zheng, S., Hu, S., Wang, Y., & Lv, Q. (2023). GSH-Responsive Prodrug Nanoassembly as a Carrier-Free Nanoplatform for Tumor-Targeting Delivery and Chemo-Photothermal Therapy. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00319
Vancouver
Tian B, Xu H, Wang H, Li K, Zheng S, Hu S, et al. GSH-Responsive Prodrug Nanoassembly as a Carrier-Free Nanoplatform for Tumor-Targeting Delivery and Chemo-Photothermal Therapy. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.3c00319
BibTeX
@article{Tian2023,
author = {Tian, Baocheng and Xu, Hong and Wang, Haiyan and Li, Keke and Zheng, Shuna and Hu, Senhao and Wang, Yongjun and Lv, Qingzhi},
title = {GSH-Responsive Prodrug Nanoassembly as a Carrier-Free Nanoplatform for Tumor-Targeting Delivery and Chemo-Photothermal Therapy},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.3c00319}
}
EUVIMED